13F Holdings
中文EN

TNDM TANDEM DIABETES CARE INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1438133 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.8%
TTM net income YoY75.8%
TTM EPS YoY76.4%
Revenue 3-yr CAGR11.7%
Net income 3-yr CAGR—

Margins

Gross margin56.6%
Operating margin-2.4%
Net margin-4.6%
FCF margin-3.4%
EBITDA margin-0.7%

Returns

ROE-36.7%
ROA-4.8%
ROIC (approx.)-3.9%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets88.3%
Debt / equity4.47x
Current ratio3.21x
Interest coverage-2.80x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-3.4%
Payout ratio—
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.01B$940.20M$747.72M$801.22M$702.80M
Cost of revenue$468.72M$450.63M$380.03M$388.23M$326.58M
Gross profit$546.01M$489.57M$367.69M$412.99M$376.21M
R&D expense$193.11M$198.88M$169.67M$139.11M$92.05M
SG&A expense$444.99M$389.82M$352.50M$335.68M$261.51M
Operating income-$187.26M-$99.13M-$233.23M-$92.85M$22.65M
Interest expense$7.91M$7.42M$9.88M$6.21M—
Pretax income-$200.27M-$91.87M-$220.25M-$92.85M$15.90M
Income tax$4.44M$4.16M$2.36M$1.74M$335,000
Net income-$204.71M-$96.03M-$222.61M-$94.59M$15.57M
EBITDA-$169.59M-$82.52M-$217.51M-$78.52M$36.50M
EPS (basic)-3.04-1.47-3.43-1.470.25
EPS (diluted)-3.04-1.47-3.43-1.470.24
Weighted avg. shares (diluted)67.28M65.45M64.97M64.15M64.35M
Balance sheet
Cash & equivalents$90.63M$69.23M$58.87M$172.52M$71.18M
Short-term investments$202.03M$369.10M$409.04M$444.38M$552.63M
Receivables$165.49M$114.58M$105.56M$114.72M$110.72M
Inventory$128.77M$149.61M$157.94M$111.12M$68.55M
Current assets$618.14M$724.49M$747.99M$849.98M$811.52M
PP&E, net$83.58M$78.15M$76.54M$68.55M$50.39M
Intangibles$11.72M$925,000$2.78M$4.63M$6.64M
Total assets$881.11M$967.66M$952.66M$1.05B$905.14M
Current liabilities$242.72M$247.05M$195.26M$165.29M$131.86M
Short-term debt—$40.67M$0——
Long-term debt$310.04M$308.27M$285.04M——
Total debt$310.04M$348.94M$285.04M——
Total liabilities$725.94M$704.56M$639.03M$612.84M$472.02M
Shareholders' equity$155.17M$263.10M$313.63M$439.95M$433.11M
Net debt$219.40M$279.70M$226.17M——
Shares outstanding68.29M66.26M65.55M64.51M63.83M
Cash flow statement
Operating cash flow-$9.72M$24.23M-$31.81M$50.46M$111.36M
Capital expenditure$19.95M$19.23M$26.80M$34.10M$14.18M
Free cash flow-$29.67M$4.99M-$58.61M$16.37M$97.18M
Investing cash flow$72.88M-$23.48M-$85.74M$33.17M-$186.88M
Financing cash flow-$43.37M$8.37M$4.11M$16.88M$51.93M
Depreciation & amortization$17.67M$16.61M$15.71M$14.33M$13.85M
Stock-based compensation$92.38M$101.38M$88.08M$84.92M$60.75M
Share buybacks$0$30.00M$0$0—

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.